Atypical hemolytic uremic syndrome

Acta Paediatr Jpn. 1995 Oct;37(5):638-41. doi: 10.1111/j.1442-200x.1995.tb03393.x.

Abstract

The pathogenesis of atypical uremic syndrome (HUS), which is rarely encountered in childhood, is poorly understood and its mortality and morbidity rates are high. A wide variety of therapeutic approaches has been attempted and the literature contains numerous conflicting reports about the results of these approaches. In a case diagnosed as recurrent atypical HUS, pulse methyl prednisolone, fresh frozen plasma infusions and plasma exchange transfusion were used at different stages of the disease with satisfactory response.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Combined Modality Therapy
  • Female
  • Hemolytic-Uremic Syndrome / therapy*
  • Humans
  • Methylprednisolone / administration & dosage
  • Plasma Exchange

Substances

  • Methylprednisolone